Simvastatin, an HMG–Coenzyme A Reductase Inhibitor, Improves Endothelial Function Within 1 Month

Ovid Technologies (Wolters Kluwer Health) - Tập 95 Số 5 - Trang 1126-1131 - 1997
G. O’Driscoll1, Daniel J. Green1, Roger R. Taylor1
1the Department of Cardiology and Medicine, Royal Perth (Australia) Hospital and the Department of Human Movement, University of Western Australia, Perth (D.G.).

Tóm tắt

Background Cholesterol-lowering therapy can improve cardiovascular morbidity and mortality in patients with atherosclerosis. Although the mechanisms responsible are unclear, these benefits precede macroscopic changes in the vasculature. Emerging evidence that improvement in endothelial function may occur requires substantiation; in particular, it is unclear how early any such improvement would be detectable after initiation of therapy. Methods and Results This randomized, double-blind, placebo-controlled crossover study evaluated the effect of simvastatin (20 mg daily for 4 weeks) on endothelium-dependent and endothelium-independent vasodilation and on the response to the inhibitor of nitric oxide synthesis, N G -monomethyl- l -arginine (L-NMMA), in the forearm vasculature of subjects with moderate elevation of total serum cholesterol (6.0 to 10.0 mmol/L) by use of strain-gauge plethysmography. Studies were repeated after 3 more months of open therapy. When the results are expressed as percentage changes in flow in the infused arm relative to the noninfused arm, the vasodilator response to acetylcholine was significantly increased after 4 weeks of treatment with simvastatin ( P <.0005), and this improvement was further enhanced after 3 months ( P <.005). Concurrently, simvastatin augmented the vasoconstrictor response to L-NMMA, an effect that was maintained at 3 months ( P <.0005). The response to the endothelium-independent vasodilator sodium nitroprusside was unaltered. Conclusions These observations indicate that within 1 month of treatment with simvastatin, both the stimulated and basal nitric oxide dilator functions of the endothelium are augmented, and the benefits of this HMG–coenzyme A reductase inhibitor persist with continued therapy.

Từ khóa


Tài liệu tham khảo

Scandinavian Simvastatin Survival Study Investigators. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344:1383-1389.

10.1161/circ.92.9.2419

10.1056/NEJM199511163332001

10.1161/circ.87.6.8504494

10.1056/NEJM199011083231901

10.1161/circ.89.6.8205659

10.1056/NEJM199502233320801

10.1056/NEJM199502233320802

10.1161/01.CIR.85.4.1390

10.1172/JCI116634

10.1016/0140-6736(92)92621-L

10.1093/cvr/21.1.34

10.1016/0021-9150(93)90265-V

10.1152/ajpcell.1989.256.3.C591

10.1016/0140-6736(93)90634-S

10.1016/S0140-6736(95)91322-X

10.1097/00004872-199209000-00017

10.1042/cs0890343

10.1161/hyp.25.5.918

10.1172/JCI116149

10.1161/circ.83.2.1991363

10.1016/0140-6736(92)93147-F

10.1016/0735-1097(94)90627-0

10.1161/circ.81.5.2110036

10.1172/JCI116183

10.1172/JCI114688

10.1111/j.1440-1681.1994.tb02442.x

10.1016/0735-1097(94)90628-9

10.1172/JCI114949

10.1172/JCI116491

Darley Usmar VM, Hogg N, O'Leary VJ, Wilson MT, Moncada S. The simultaneous generation of superoxide and nitric oxide can initiate lipid peroxidation in human low density lipoprotein. Free Radic Res. 1992;17:9-20.

10.1161/circ.83.6.2040054

10.1016/0140-6736(91)92372-9

Cooke JP, Dzau J, Creager A. Endothelial dysfunction in hypercholesterolemia is corrected by l-arginine. Basic Res Cardiol. 1991;86:173-181.

10.1172/JCI115987

10.1161/circ.88.6.8252665

10.1161/circ.93.9.1647

10.1016/S0002-9149(99)80327-0

10.1016/S1043-6618(05)80119-7

10.1056/NEJM199509073331003

10.1161/circ.92.11.3172

10.1016/0005-2760(93)90145-Y

Thông tin
Thông tin xuất bản

Ovid Technologies (Wolters Kluwer Health)

Tập 95 Số 5

1126-1131

Thông tin tác giả